Nevada to receive $193 million from Teva; opioid settlements to state top $856 million

Attorney General Aaron Ford’s office announced Wednesday that Nevada will receive an additional $193 million from Teva Pharmaceuticals through one of the state’s many settlements with major companies involved in the opioid epidemic. Under the settlement, Teva will make annual payments to the state from July 2024 through July 2043, starting at $7 million and increasing on a sliding scale until reaching $27 million in 2042. Teva will also stop the promotion of opioids and opioid products in Nevada.